(Q34066971)

30 July 2017

1 reference

title

Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s (English)

1 reference

30 July 2017

0 references

0 references

Berchtold NC

1 reference

30 July 2017

Cotman CW

series ordinal

1 reference

30 July 2017

publication date

1 May 1998

1 reference

30 July 2017

published in

Neurobiology of Aging

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

173-189

1 reference

Amyloidosis of Alzheimer's disease: a clue to ageing?

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Cognitive and neurobiologic markers of early Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Origin of the distinction between Alzheimer's disease and senile dementia: How history can clarify nosology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The history of Alzheimer's disease: three debates.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Mitochondria, free radicals, and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Serum proteins, amyloid and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Dementia during the seventeenth and eighteenth centuries: a conceptual history

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The role of estrogen in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Usual vs. successful aging: some notes on experiential factors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Alzheimer's disease and THA: a review of the cholinergic theory and of preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Staging of Alzheimer's disease-related neurofibrillary changes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Functional imaging techniques in the diagnosis of non-Alzheimer dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

A potential role for apoptosis in neurodegeneration and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Mechanisms of neuronal death in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Tacrine: first drug approved for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Strategies for the development of therapeutics for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Amyloidosis, Alzheimer's disease, and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Oxidative stress and apoptosis in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Auguste D and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Binswanger's disease: neither Binswanger's nor a disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Auguste D and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

ALZHEIMER'S DISEASE WITH PREDOMINATING CROSSED CEREBRO-CEREBELLAR HEMIATROPHY.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The epidemiology of estrogen replacement therapy and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Cognitive performance in a high-functioning community-dwelling elderly population.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The role of the electroencephalogram in the diagnosis of dementia of the Alzheimer type: an attempt at technology assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Molecular aspects of inflammatory and immune responses in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Editorial: The prevalence and malignancy of Alzheimer disease. A major killer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Calcium hypothesis of Alzheimer's disease and brain aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Neurodegeneration in Alzheimer disease. Is apoptosis involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Chronic brain ischemia: the contributions of Otto Binswanger and Alois Alzheimer to the mechanisms of vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Auguste D and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Hormone replacement therapy and other potential treatments for dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Anti-inflammatory drugs in the fight against Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

ALZHEIMER'S DISEASE: A REPORT OF SIX CASES.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

A CRITICAL REVIEW: DEMENTIA IN MIDDLE AGE.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The study of neurological disorders using positron emission tomography and single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Application of PET in dementia disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Auguste D. and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Inflammation and Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

APOE is a major susceptibility gene for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The natural history of mental disorder in old age.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Psychological test performance in patients over sixty. I. Senile psychosis and the affective disorders of old age.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Correlation between scores for dementia and counts of 'senile plaques' in cerebral grey matter of elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Diagnostic testing and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Historical aspects of neurosciences Otto Binswanger (1852–1929)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Historical essay: Kraepelin's description of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Behavioral and psychosocial predictors of physical performance: MacArthur studies of successful aging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Alzheimer's disease: a central role for amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Amyloid beta-protein and the genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Oxidative stress in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Use of structural imaging to study the progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Quantitative computed tomography and magnetic resonance imaging in aging and Alzheimer's disease. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Radical AGEing in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

THE FINE STRUCTURE OF NEUROFIBRILLARY TANGLES IN ALZHEIMER'S DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Relationship between plaques, tangles, and dystrophic processes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Clinical subgroups of the Alzheimer syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

1 reference

7 January 2021

Review. David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Magnetic resonance imaging of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900052-9

7 January 2021

10.1016/S0197-4580(98)00052-9

Identifiers

DOI

1 reference

30 July 2017

1 reference